Open AccessTranscatheter arterial chemoembolization combined with low-dose apatinib in the treatment of unresectable hepatocellular carcinoma in elderly patients: Efficacy and safety
Author(s) -
Song Liu,
Guangsheng Zhao,
Guangji Yu,
Nannan Guo,
Yuewei Zhang,
Qiang Li,
Zhe Wang
Publication year - 2020
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_1030_19
Subject(s) - apatinib , medicine , hepatocellular carcinoma , adverse effect , gastroenterology , transcatheter arterial chemoembolization , incidence (geometry) , population , surgery , overall survival , physics , environmental health , optics
Owing to the increasing age of the population, the incidence of hepatocellular carcinoma (HCC) in the elderly is increasing annually.